BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Neuronetics, Inc. 

One Great Valley Parkway
Suite 2
Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-640-4202 Fax: 610-640-4206


SEARCH JOBS




Industry
Medical Device






 Company News
Neuronetics, Inc. Release: Neurostar TMS Therapy® Shows Promise As Effective Once-Monthly Maintenance Therapy In Patients With Major Depressive Disorder 5/6/2014 9:28:26 AM
Neuronetics, Inc. Release: Data Published in CNS Spectrums Indicate Acute Transcranial Magnetic Stimulation (TMS) With NeuroStar TMS Therapy® Improves Quality of Life in Patients with Depression 9/16/2013 11:03:16 AM
Neuronetics, Inc., Announces First Patients Enrolled in Clinical Trial to Evaluate NeuroStar TMS Therapy in Women with Postpartum Depression 7/30/2013 9:20:36 AM
Neuronetics, Inc. Release: New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients With Depression using NeuroStar TMS Therapy System 5/22/2013 9:41:13 AM
Neuronetics, Inc. Release: NeuroStar TMS Therapy, a Non-Drug Depression Treatment, Demonstrates Statistically Significant Benefits on Patient-Reported Pain Outcomes 3/20/2013 8:51:47 AM
Neuronetics, Inc., Honored with Prestigious Industry Award for the NeuroStar TMS Therapy® System at Phoenix 2012 Conference 10/18/2012 1:00:07 PM
Neuronetics, Inc. Receives CE Mark Approval for NeuroStar TMS Therapy 6/4/2012 8:11:07 AM
Neuronetics, Inc. Release: Non-Drug Depression Treatment Rapidly and Significantly Improves Disease Symptoms and Quality of Life 5/9/2012 9:59:40 AM
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With Neuronetics, Inc.'s NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting 5/16/2011 7:44:53 AM
Neuronetics, Inc. Raises $30 Million in Series E Financing 5/16/2011 7:33:58 AM
123